Literature DB >> 9496827

Prognosis in malignant mesothelioma related to MIB 1 proliferation index and histological subtype.

T W Beer1, R Buchanan, A W Matthews, R Stradling, N Pullinger, R J Pethybridge.   

Abstract

The aims of this study were to evaluate the use of the proliferation marker MIB 1 and histological subtype as indicators of prognosis in malignant mesothelioma. Sections from 41 cases of malignant mesothelioma were histologically subtyped on hematoxylin and eosin sections and stained immunohistochemically for the proliferation marker MIB 1. A proliferation index was derived and the results compared with patient survival data. A statistically significant difference was found between the survival of patients having a low and high MIB 1 index (P < .001). Patients with tumors having a low MIB 1 index lived significantly longer than those with a high MIB 1 index. Patients with the spindle cell histological subtype of malignant mesothelioma had significantly shorter survival times than those with the epithelioid or mixed tumors (P < .01). The MIB 1 proliferation index and histological tumor subtype are useful markers of prognosis in malignant mesothelioma.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9496827     DOI： 10.1016/s0046-8177(98)90043-0

Source DB:  PubMed          Journal:  Hum Pathol        ISSN： 0046-8177            Impact factor:   3.466


  9 in total

1.  Expression of E-cadherin, b-catenin, and Ki-67 in goblet cell carcinoids of the appendix: an immunohistochemical study with clinical correlation.

Authors:  Chiun Chei Li; Mitsuyoshi Hirowaka; Zhi Rong Qian; Bing Xu; Toshiaki Sano
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

2.  Malignant mesothelioma of the peritoneum: case reports and immunohistochemical findings including Ki-67 expression.

Authors:  Hiroshi Hirano; Takashi Fujisawa; Koichi Maekawa; Eriko Ohkubo; Akira Okimura; Kozo Kuribayashi; Takashi Nakano; Keiji Nakasho; Takashi Nishigami
Journal:  Med Mol Morphol       Date:  2010-03-26       Impact factor: 2.309

3.  A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma.

Authors:  Kyuichi Kadota; Kei Suzuki; Christos Colovos; Camelia S Sima; Valerie W Rusch; William D Travis; Prasad S Adusumilli
Journal:  Mod Pathol       Date:  2011-10-07       Impact factor: 7.842

Review 4.  Overexpressed genes in malignant pleural mesothelioma: implications in clinical management.

Authors:  Elisa Barone; Federica Gemignani; Stefano Landi
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

5.  Correlation of bcl-2 oncoprotein immunohistochemical expression with proliferation index and histopathologic parameters in colorectal neoplasia.

Authors:  H A Saleh; H Jackson; G Khatib; M Banerjee
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

Review 6.  Peritoneal mesothelioma: a review.

Authors:  Alessio Bridda; Ilaria Padoan; Roberto Mencarelli; Mauro Frego
Journal:  MedGenMed       Date:  2007-05-10

7.  Factors influencing long-term survival in mesothelioma patients--results of the German mesothelioma register.

Authors:  V Neumann; A Rütten; M Scharmach; K-M Müller; M Fischer
Journal:  Int Arch Occup Environ Health       Date:  2004-02-27       Impact factor: 3.015

8.  Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma.

Authors:  Y Ito; N Matsuura; M Sakon; T Takeda; K Umeshita; H Nagano; S Nakamori; K Dono; M Tsujimoto; M Nakahara; K Nakao; M Monden
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

9.  Posterior Mediastinal Adenomatoid Tumor: A Case Report and Review of the Literature.

Authors:  Vishwas Parekh; Thomas Winokur; Robert J Cerfolio; Todd M Stevens
Journal:  Case Rep Pathol       Date:  2016-05-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.